The Claim
In elderly obese adults, administration of semaglutide in combination with diet and exercise for 16 weeks improves the fat-to-lean mass ratio by approximately 0.08 units.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In elderly adults with obesity, taking semaglutide along with diet and exercise for 16 weeks results in a measurable improvement in body composition, with a 0.08 unit increase in the fat-to-lean mass ratio.
See the scientific wording
In elderly obese adults, semaglutide combined with diet and exercise for 16 weeks improves the fat-to-lean mass ratio by approximately 0.08 units, indicating a shift toward a healthier body composition profile.
Semaglutide activates receptors in the brain and fat tissue that reduce appetite and fat storage, while signals from the brain protect muscle from breaking down during weight loss.
What the research says
1 studyIn older adults with obesity, taking semaglutide along with diet and exercise for 4 months helped them lose more fat than muscle, improving their body shape. The study showed exactly the 0.08 improvement in fat-to-muscle ratio that the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.